ORGANOGENESIS HOLDINGS INC.

ORGO · NASDAQ

Research and Development in Biotechnology · US

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Market Data

Price $2.34 -0.04 (-1.68%)

Market Cap$301M

P/E Ratio110.74

EPS$—

52W High$7.08

52W Low$2.04

Beta1.37

Data from Finnhub · Updated Jun 15, 2026